This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Differential Effects on Signs and Symptoms

Donald R. Jasinski, MD; Rolley E. Johnson, PharmD; Theresa R. Kocher

Arch Gen Psychiatry. 1985;42(11):1063-1066.

Abstract
• Reports of an antiwithdrawal effect for clonidine hydrochloride in acute opioid withdrawal are inconsonant with experimental findings that other nonopioids are ineffective. In the present investigation the antiwithdrawal effects of clonidine, morphine sulfate, and placebo were compared in volunteer addicts whose dependence was maintained by 15 mg of morphine sulfate given subcutaneously four times daily. Clonidine was effective but had a differential effect on the signs and symptoms of morphine abstinence. Compared with morphine, clonidine was more effective in suppressing autonomic signs of abstinence but less effective in reducing subject-reported symptoms and discomfort. It is concluded that the perception of the clinical usefulness of clonidine depends on whether objective measures or subjects' reports are treated.

Author Affiliations
From the Department of Health and Human Services, Public Health Service, Alcohol, Drug Abuse and Mental Health Administration, National Institute on Drug Abuse, Addiction Research Center, Baltimore.

Footnotes
Accepted for publication Sept 27, 1984.

Reprint requests to National Institute on Drug Abuse, Addiction Research Center, PO Box 5180, Baltimore, MD 21224 (Dr Jasinski).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Cocaine and Other Indirect-Acting Monoamine Agonists Differentially Attenuate a Naltrexone Discriminative Stimulus in Morphine-Treated Rhesus Monkeys
McMahon et al.
J. Pharmacol. Exp. Ther. 2004;308:111-119.
ABSTRACT | FULL TEXT  

Management of Drug and Alcohol Withdrawal
Kosten and O'Connor
NEJM 2003;348:1786-1795.
FULL TEXT  

Cocaine and Amphetamine Attenuate the Discriminative Stimulus Effects of Naltrexone in Opioid-Dependent Rhesus Monkeys
Sell and France
J. Pharmacol. Exp. Ther. 2002;301:1103-1110.
ABSTRACT | FULL TEXT  

Chronic l-alpha -Acetylmethadol (LAAM) in Rhesus Monkeys: Tolerance and Cross-Tolerance to the Antinociceptive, Ventilatory, and Rate-Decreasing Effects of Opioids
Brandt and France
J. Pharmacol. Exp. Ther. 2000;294:168-178.
ABSTRACT | FULL TEXT  

Activation of Coeruleospinal Noradrenergic Inhibitory Controls during Withdrawal from Morphine in the Rat
Rohde and Basbaum
J. Neurosci. 1998;18:4393-4402.
ABSTRACT | FULL TEXT  

Inhibition of Reinforcing Effects of Morphine and Motivational Aspects of Naloxone-Precipitated Opioid Withdrawal by N-Methyl-D-aspartate Receptor Antagonist, Memantine
Popik and Danysz
J. Pharmacol. Exp. Ther. 1997;280:854-865.
ABSTRACT | FULL TEXT  

Clonidine Prophylaxis for Narcotic and Sedative Withdrawal Syndrome Following Laryngotracheal Reconstruction
Deutsch and Nadkarni
Arch Otolaryngol Head Neck Surg 1996;122:1234-1238.
ABSTRACT  

Effects of Transdermal Clonidine Treatment on Withdrawal Symptoms Associated With Smoking Cessation: A Randomized, Controlled Trial
Ornish et al.
Arch Intern Med 1988;148:2027-2031.
ABSTRACT  

Heavy Smokers, Smoking Cessation, and Clonidine: Results of a Double-blind, Randomized Trial
Glassman et al.
JAMA 1988;259:2863-2866.
ABSTRACT  

Impact of Clonidine on Alcohol Withdrawal States-Reply
Baumgartner and Rowen
Arch Intern Med 1988;148:245-245.
ABSTRACT  

Clonidine vs Chlordiazepoxide in the Management of Acute Alcohol Withdrawal Syndrome
Baumgartner and Rowen
Arch Intern Med 1987;147:1223-1226.
ABSTRACT